A single-center randomized, active-controlled, observer-blinded, parallel group trial to evaluate the efficacy and safety of a topical dimeticone formulation (Loion®) compared to 10% saliclylic acid in octyldodecanol with 15% Macrogol-4-laurylether in the removal of psoriatic plaques in patients with chronic psoriasis capitis (scalp psoriasis).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dimeticone (Primary) ; Salicylic acid
- Indications Psoriasis
- Focus Registrational; Therapeutic Use
- 05 Nov 2014 Biomarkers information updated
- 05 Aug 2013 New source identified and integrated: ClinicalTrials.gov record.
- 02 Jul 2013 New trial record